Publications by authors named "Sıtkı Safa Taflan"
Objective: Vascular involvement is an important cause of morbidity and mortality in patients with Behçet's syndrome (BS). We aimed to survey the efficacy and safety of infliximab (IFX) in BS patients with vascular involvement followed in a dedicated tertiary center.
Methods: Charts of all BS patients who used IFX for vascular involvement between 2004 and 2022 were reviewed.